Download Free Sample Report

The global Short Sleep Syndrome Treatment market was valued at US$ 8941.6 million in 2023 and is projected to reach US$ 15930.3 million by 2030, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Benzodiazepines Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Short Sleep Syndrome Treatment include Merck & co., Mylan N.V., Paratek pharmaceuticals, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon pharma Co. Ltd., Takeda Pharmaceuticals Company Ltd., Teva Pharmaceutical Industries Ltd. and Vanda Pharmaceuticals Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Short Sleep Syndrome is a sleep condition characterized by sleeping for fewer than six hours each night . Most adults need seven or more hours of sleep each night to feel rested in the morning.
This report aims to provide a comprehensive presentation of the global market for Short Sleep Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Sleep Syndrome Treatment. This report contains market size and forecasts of Short Sleep Syndrome Treatment in global, including the following market information:

• Global Short Sleep Syndrome Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Short Sleep Syndrome Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Short Sleep Syndrome Treatment companies in 2023 (%)

We surveyed the Short Sleep Syndrome Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Short Sleep Syndrome Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short Sleep Syndrome Treatment Market Segment Percentages, by Type, 2023 (%)

• Benzodiazepines
• Nonbenzodiazepines
• Antidepressants
• Orexin Antagonist
• Melatonin Antagonist
• Other

Global Short Sleep Syndrome Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short Sleep Syndrome Treatment Market Segment Percentages, by Application, 2023 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Short Sleep Syndrome Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Short Sleep Syndrome Treatment Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Short Sleep Syndrome Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Short Sleep Syndrome Treatment revenues share in global market, 2023 (%)
• Key companies Short Sleep Syndrome Treatment sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Short Sleep Syndrome Treatment sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck & co.
• Mylan N.V.
• Paratek pharmaceuticals
• Pfizer Inc.
• Sanofi S.A.
• Sumitomo Dainippon pharma Co. Ltd.
• Takeda Pharmaceuticals Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Vanda Pharmaceuticals Inc.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Short Sleep Syndrome Treatment, market overview.
Chapter 2: Global Short Sleep Syndrome Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Short Sleep Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Short Sleep Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Short Sleep Syndrome Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.